Serum Protein Electrophoresis Findings in Multiple Myeloma
The typical serum protein electrophoresis (SPEP) finding in multiple myeloma is a monoclonal protein (M-protein) appearing as a sharp, narrow band or spike (M-spike) most commonly in the gamma or beta region of the electrophoresis pattern. 1, 2
Key SPEP Findings in Multiple Myeloma
M-protein appears as a narrow band in agarose electrophoresis or as a sharp symmetric spike (M-spike) in capillary zone electrophoresis, representing the clonal proliferation of plasma cells 1, 2
The M-protein is most commonly found in the gamma or beta regions, though rarely it can appear in the alpha-2 region 3
The M-protein can consist of:
- Complete immunoglobulin with both heavy and light chains (most common)
- Light chains only
- Heavy chains only (rare) 3
Quantification of the M-protein on SPEP helps track disease progression and response to treatment 2
Distribution of M-Protein Types in Multiple Myeloma
Most patients (approximately 97%) have detectable serum M-proteins with or without associated urinary M-proteins 2
About 20% of patients have secretory urinary M-proteins in addition to serum M-proteins 2
Approximately 3% of patients have neither serum nor urine M-proteins, classified as nonsecretory myeloma 2
Complementary Testing to SPEP
Serum immunofixation electrophoresis (SIFE) should follow SPEP to specifically identify the type of M-protein (IgG, IgA, IgM, kappa or lambda light chains) 1, 2, 4
Quantitative immunoglobulin levels (IgG, IgA, IgM) help assess the extent of normal immunoglobulin suppression 1, 2
Serum free light chain (FLC) assay is essential for:
24-hour urine collection for total protein, urine protein electrophoresis (UPEP), and urine immunofixation electrophoresis (UIFE) should be performed to detect Bence Jones proteinuria 1, 2
Clinical Interpretation and Pitfalls
An M-spike on SPEP is not specific for multiple myeloma and can be seen in other conditions:
Rare cases may show atypical patterns:
The serum FLC assay cannot replace 24-hour UPEP for monitoring patients with measurable urinary M-proteins 2
For accurate relative quantification in disease monitoring, it's crucial to use the same test method for serial studies 2
Prognostic Implications
The type and quantity of M-protein detected by SPEP has prognostic significance 1, 2
Beta-2 microglobulin, often measured alongside SPEP, reflects tumor mass and is a standard measure of tumor burden in multiple myeloma 1, 7
The combination of beta-2 microglobulin with serum albumin forms the International Staging System (ISS), a powerful prognostic tool 7